GLP-1 drugs are now part of the conversation across military healthcare. Medications like Wegovy, Ozempic, and others are covered under TRICARE, but not in the way most families expect. Across military communities, the message has been reduced to a headline that says these drugs are finally covered. But once families try to access them, the process looks very different. Coverage does exist, but approval is conditional.

For beneficiaries enrolled in TRICARE Prime or Select, GLP-1 medications may be covered if strict clinical criteria are met and a prior authorization is approved. For others, including many retirees using TRICARE For Life, coverage for weight-loss medications does not apply under the current policy tied to Medicare rules. That difference is where most confusion starts.

What TRICARE Actually Confirms

The official guidance from TRICARE is clear on a few points, such as that patients must meet clinical criteria, have a valid prescription, and complete prior authorization with documentation showing medical necessity for these drugs.

What TRICARE does not do is lay out those criteria in a way most patients can easily follow. The standards exist, but they are applied through the pharmacy contractor, Express Scripts, during the review process rather than explained step-by-step in official guidance. Patients go in knowing the rules exist, but not exactly how they’re being measured against them.

Nobody Prepared You for Military Life

But we can help. Join over 100k spouses already getting the advice, resources, and military tea they need to thrive.

​

Subscribe

Always free. Unsubscribe anytime.

Why the Prescription Isn’t Enough

Prior authorization is not a formality when it decides everything. Providers must submit documentation that aligns with TRICARE’s internal criteria. If something is missing or does not meet those thresholds, the request can be denied even with a valid prescription.

There is no publicly available approval rate or standard timeline for drug approval that families can rely on. What is confirmed is the requirement for prior authorization. What isn’t, is how often approvals succeed on the first attempt.

Not All GLP-1 Coverage Works the Same

Coverage depends not just on the drug, but on why it is prescribed. GLP-1 medications used to treat type 2 diabetes generally follow a more standard coverage pathway under TRICARE’s pharmacy benefit, typically still requiring prior authorization but with broader eligibility.

The same class of drugs, when prescribed for weight management, falls under stricter rules. Coverage is limited to patients who meet specific clinical criteria and receive approval through the prior authorization process.

Same medication category, different purpose, different outcome.

Who Gets Access and Who Doesn’t

Eligibility depends on both plan and clinical criteria. TRICARE Prime and Select beneficiaries may qualify if they meet the requirements and complete prior authorization successfully. That includes many active duty family members and some retirees.

Under current TRICARE guidance, beneficiaries using TRICARE For Life are not eligible for coverage of weight-loss medications like Wegovy. This is tied to Medicare coverage rules and how TRICARE coordinates benefits, not a standalone expansion or rollback of TRICARE policy.

The result is a split system. Some families can pursue coverage through a controlled process. Others are excluded from the start.

Why This Feels More Accessible Than It Is

There has been no broad policy announcement opening access to GLP-1 medications across TRICARE. What exists instead is a structured pathway for coverage, shaped by medical necessity requirements and administrative controls.

These medications are expensive, demand is high, and federal healthcare programs, including TRICARE, are managing access rather than expanding it without limits. So while coverage is real, it is tightly filtered.

What This Means in Real Terms

For military families, this process is not straightforward. It means working with a provider who understands what TRICARE requires for approval, navigating prior authorization without clear timelines, and the possibility of denial without a detailed explanation.

If coverage is not approved, the financial impact is immediate. GLP-1 medications can cost more than $1,000 per month out of pocket. Some families will get through the process. Others won’t.

From the outside, the difference can feel unclear or confusing. GLP-1 drugs are covered under TRICARE, and patients should talk with their doctor about this treatment option and seek prior authorization to better understand what it takes to actually access them.